Akebia director granted RSUs and stock options
Akebia Therapeutics director Myles Wolf received equity awards as part of non-employee director compensation.
Rhea-AI Filing Summary
Akebia Therapeutics director Myles Wolf received equity awards as part of non-employee director compensation. He was granted 35,700 shares of Common Stock in the form of restricted stock units and a stock option for 53,600 shares at an exercise price of $1.02 per share. Both the RSUs and the option vest 100% on the first anniversary of the June 17, 2026 grant date, or earlier immediately before the first annual stockholder meeting after the grant, if that occurs sooner, subject to his continued service. Following the award, he directly owns 169,081 Common Shares and holds the newly granted option for 53,600 underlying shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 89,300 shares
Grant/Award
2 txns
Insider
Wolf Myles
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to buy) | 53,600 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 35,700 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to buy) — 53,600 contracts (Direct);
Common Stock — 169,081 shares (Direct)
Footnotes (2)
- F1. The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date.
- F2. The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Key Figures
RSU grant: 35,700 shares
Stock option grant: 53,600 shares
Option exercise price: $1.02 per share
+3 more
6 metrics
RSU grant
35,700 shares
Restricted stock units granted June 17, 2026
Stock option grant
53,600 shares
Option covering common stock granted June 17, 2026
Option exercise price
$1.02 per share
Conversion or exercise price of new option
Shares after transaction
169,081 shares
Common stock directly owned following grant
Option expiration
June 17, 2036
Expiration date of stock option
RSU vesting
100% after 1 year
Full vesting on first anniversary or earlier before annual meeting
Key Terms
restricted stock units, 2023 Stock Incentive Plan, Non-Employee Director Compensation Program, Stock Option, +1 more
5 terms
restricted stock units financial
"The restricted stock units (the "RSUs") were granted by the Issuer"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2023 Stock Incentive Plan financial
"were granted by the Issuer pursuant to its 2023 Stock Incentive Plan"
Non-Employee Director Compensation Program financial
"as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program"
Stock Option financial
"The option to purchase shares of the Issuer's common stock (the "Stock Option")"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest in full (100%) financial
"The RSUs will vest in full (100%) on the first anniversary"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Akebia Therapeutics (AKBA) director Myles Wolf receive?
Myles Wolf received 35,700 restricted stock units and a stock option for 53,600 Akebia Therapeutics common shares. Both grants are compensation awards under the company’s 2023 Stock Incentive Plan and its non-employee director compensation program.
What is the exercise price and term of Myles Wolf’s new Akebia (AKBA) stock option?
The stock option granted to Myles Wolf covers 53,600 shares at an exercise price of $1.02 per share. It was granted June 17, 2026 and is scheduled to expire on June 17, 2036 if not exercised, subject to plan terms.
When do Myles Wolf’s Akebia Therapeutics (AKBA) RSUs and options vest?
Both the 35,700 restricted stock units and the 53,600-share stock option vest 100% on the first anniversary of the June 17, 2026 grant date, or earlier immediately before the first annual stockholder meeting after grant, contingent on his continuous service.
Under which plans were Myles Wolf’s Akebia (AKBA) equity awards granted?
The restricted stock units and stock option were granted under Akebia’s 2023 Stock Incentive Plan. They were provided pursuant to the company’s Fifth Amended and Restated Non-Employee Director Compensation Program governing director equity compensation.
AI-generated analysis. How Rhea-AI works. Not financial advice.
